Novavax Files 8-K on Security Holder Vote Matters
Ticker: NVAX · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1000694
| Field | Detail |
|---|---|
| Company | Novavax Inc (NVAX) |
| Form Type | 8-K |
| Filed Date | Jun 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
NOVAVAX is calling for a shareholder vote on June 20th - details to come.
AI Summary
On June 20, 2025, Novavax, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The filing does not disclose specific details about the matters to be voted on or any associated financial implications.
Why It Matters
This filing indicates that Novavax is seeking shareholder approval for certain corporate actions, which could impact the company's future direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is procedural and does not contain information that immediately suggests significant financial or operational risk.
Key Players & Entities
- Novavax, Inc. (company) — Registrant
- June 20, 2025 (date) — Date of earliest event reported
FAQ
What specific matters will be submitted for a vote by Novavax's security holders?
The filing does not specify the exact matters to be voted on, only that a submission of matters to a vote of security holders is occurring.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 20, 2025.
What is Novavax, Inc.'s principal executive office address?
Novavax, Inc.'s principal executive office is located at 700 Quince Orchard Road, Gaithersburg, Maryland 20878.
What is Novavax's telephone number?
Novavax's telephone number is (240) 268-2000.
Under which section of the Securities Exchange Act is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding NOVAVAX INC (NVAX).